Determination of hepatitis C virus subtype prevalent in Sindh, Pakistan: a phylogenetic analysis
-
Published:2024-05-15
Issue:1
Volume:14
Page:
-
ISSN:2045-2322
-
Container-title:Scientific Reports
-
language:en
-
Short-container-title:Sci Rep
Author:
Farooq SabaORCID, Faiz Sirmast, Wahab Atia-tul, Choudhary M. Iqbal
Abstract
AbstractHepatitis is a major public health issue, affecting 10–17 million people worldwide, with its prevalence continuously increasing. The Hepatitis C virus (HCV) is responsible for liver related diseases, which include liver cirrhosis, hepatocellular carcinoma, and chronic hepatitis. Pakistan is experiencing a serious rise in HCV cases. This study aimed to assess the prevalence and distribution of HCV genotypes in Sindh, Pakistan. Serum samples from HCV-positive patients were collected from various local hospitals in Sindh. These samples were first screened for HCV antibodies using ELISA. Samples that tested positive for HCV RNA underwent further genotyping through sequencing using the standard Sanger method. The genotypes were identified by comparing the sequences with those available in the National Center for Biotechnology Information (NCBI) database, and a phylogenetic tree was constructed. The phylogenetic analysis showed that all isolates in this study were clustered with genotypes 3a and 3b, except for one sequence that was clustered with genotype 1a. No isolates were found to be clustered with reference genomes of genotypes 2, 4, 5, 6, and 7 suggesting that genotype 3a is endemic in this region. The analyzed sequences demonstrated a 98% similarity with reference and isolated sequences. In summary, sequencing of the HCV 5′ UTR essential for identifying the predominant genotype of HCV RNA in the Sindh region Further research on the distribution of HCV genotypes in other regions of Pakistan could aid in improving screening processes, identifying more effective treatment options, and developing suitable prevention strategies.
Funder
International Center for Chemical and Biological Sciences, University of Karachi Mediagnost, Gesellschaft für Forschung und Herstellung von Diagnostika GmbH
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Bhattacharjee, C., Singh, M., Das, D., Chaudhuri, S. & Mukhopadhyay, A. Current therapeutics against HCV. Virus Dis. 32, 228–243 (2021). 2. Ahmad, N., Asgher, M., Shafique, M. & Qureshi, J. A. An evidence of high prevalence of Hepatitis C virus in Faisalabad. Saudi Med. J. 28(3), 390–395 (2007). 3. Craxì, A., Laffi, G. & Zignego, A. L. Hepatitis C virus (HCV) infection: A systemic disease. Mol. Asp. Med. 29(1–2), 85–95 (2008). 4. Alavian, S. E., Heiat, M. & Ranjbar, R. A comprehensive overview of hepatitis virus genotyping methods. NBM 11(2), 89–97 (2023). 5. Sagnelli, E., Macera, M., Russo, A., Coppola, N. & Sagnelli, C. Epidemiological and etiological variations in hepatocellular carcinoma. Infection 48, 7–17 (2020).
|
|